cancel
Showing results for 
Show  only  | Search instead for 
Did you mean: 
  • DownloadSemiconductor Toolkit: Tools to create wafer maps, add wafer geometry to graphics, explore die defects & compare wafers.
  • Discovery Summit 2026: Early User Edition - September 23-24.Register. It's free.
  • Use JMP Clinical with CDISC-compliant data. Review studies, ID safety and efficacy signals & communicate findings with interactive graphics. Register to see how. Aug. 27, 2 pm US ET.

Learn JMP Events

Events designed to further your knowledge and exploration of JMP.
Choose Language Hide Translation Bar

Characterizing and Comparing Dissolution Profiles for New Drug Formulations - Mastering JMP

Presented in English
Published on ‎01-10-2025 03:09 PM by Community Manager Community Manager | Updated on ‎11-04-2025 03:43 PM

Video was recorded in February 2025 using JMP 18.

Do you need to formulate drug products to match a specific dissolution profile?   Do you need to re-formulate or validate that changes in raw material suppliers do not change a drug's dissolution profile? Do you develop dissolution methods for product release?

In this session, we will:

  • Compare a new formulation's dissolution profile to an existing formulation to determine similarity using Graph Builder and Fit Curve (eg., F2 Analysis and Higuchi models).
  • Determine how we can modify the formulation to achieve a dissolution profile that is more similar to the existing formulation by deploying  JMP Pro Curve DOE Analysis.

Suggested Prerequisites:

  • Some experience fitting curves to non-linear data.
  • Familiarity  with DOE.
  • Locate Fit Curve and Graph Builder platforms in JMP.  These one-page guides/videos may be helpful:

After you use the attached journal to try the techniques in the video, consider using the companion Hands-On Activity created by statistician and JMP Educator @Di_Michelson  for further practice:  Comparing Dissolution Curves Hands-On Activities and Solutions.

Resources

 



Start:
Fri, Feb 21, 2025 02:00 PM EST
End:
Fri, Feb 21, 2025 03:00 PM EST
Attachments
0 Comments